Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.19%||163.53||0.7%||$1333.35m|
|LLY||Eli Lilly & Co.||0.74%||323.99||1.1%||$1075.80m|
|BMY||Bristol-Myers Squibb Co.||-0.01%||70.53||1.0%||$772.67m|
|MRK||Merck & Co., Inc.||0.46%||87.96||0.7%||$713.70m|
|ALNY||Alnylam Pharmaceuticals, Inc.||0.00%||196.79||8.2%||$217.39m|
|ATXI||Avenue Therapeutics, Inc.||42.66%||16.42||0.0%||$198.73m|
|GBT||Global Blood Therapeutics, Inc.||0.00%||68.48||5.4%||$191.16m|
|IDXX||IDEXX Laboratories, Inc.||1.10%||340.39||3.9%||$186.31m|
|HZNP||Horizon Therapeutics Plc||0.00%||64.26||5.4%||$173.65m|
|SRPT||Sarepta Therapeutics, Inc.||0.00%||109.94||12.4%||$136.73m|
Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development and commercialization of a pipeline of novel and targeted oncology therapies. Its product pipeline includes: Eflapegrastim, Poziotinib, and IGN002. The company was founded in December 1987 and is headquartered in Henderson, NV.